NeuBase Therapeutics, Inc. (NBSE)

NeuBase Therapeutics Analyst Ratings

• Total Analysts: n/a
• Consensus Rating: n/a
• Price Target: n/a
• Upside: n/a

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Hartaj Singh Oppenheimer	Oppenheimer	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Oct 21, 2022
Leonid Timashev RBC Capital	RBC Capital	Buy → Hold Downgrades $240 → $20	Buy → Hold	Downgrades	$240 → $20	+5,191.01%	Oct 18, 2022
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Oct 17, 2022
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $180 → $140	Strong Buy	Maintains	$180 → $140	+36,937.04%	Aug 12, 2022
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $300 → $200	Strong Buy	Maintains	$300 → $200	+52,810.05%	May 31, 2022
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $360 → $180	Strong Buy	Maintains	$360 → $180	+47,519.05%	May 13, 2022
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains n/a	Strong Buy	Maintains	n/a	n/a	Jun 1, 2021
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains n/a	Strong Buy	Maintains	n/a	n/a	Feb 12, 2021
Brian Abrahams RBC Capital	RBC Capital	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Jun 16, 2020
Hartaj Singh Oppenheimer	Oppenheimer	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Apr 1, 2020
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains n/a	Strong Buy	Maintains	n/a	n/a	Apr 1, 2020
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Mar 6, 2020
Whitney Ijem Guggenheim	Guggenheim	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Feb 7, 2020